Dataset from A Randomized, Subject and Investigator Blinded, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis

Name: Dataset from A Randomized, Subject and Investigator Blinded, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-05-10 收录

下载链接：

https://doi.org/10.25934/PR00012408

下载链接

链接失效反馈

官方服务：

资源简介：

The main purpose of this phase 2 study was to assess the efficacy and safety of CMK389 in patients with atopic dermatitis.

创建时间：

2025-12-16